Literature DB >> 15991049

[Experiences with surgical management of facial basal cell carcinoma and procedures for plastic reconstruction].

J Rustemeyer1, V Thieme, L Günther, A Bremerich.   

Abstract

BACKGROUND: No recurrences and optimal aesthetic outcomes after R0 resection and plastic reconstruction of the face are the goals in the surgical treatment of basal cell carcinoma. The aim of this study was to evaluate recurrence rates and to evaluate different reconstructive techniques. PATIENTS AND METHODS: This study included 205 follow-up patients undergoing R0 resection of primary basal cell carcinoma and facial skin reconstruction between 1998 and 2002; data were analyzed retrospectively.
RESULTS: The most frequent locations of basal cell carcinoma were the nasal (40.5%) and orbital (22.9%) regions. The rate of recurrence after 2.5 years (6 months-5 years) was 7.3%. Local flaps, full-thickness skin grafts, and sliding flaps were usually performed; indications for split-thickness skin grafts were rare. Disturbances of sensation were found in only 3.6% of the sliding flaps and in 11.7% of the local flaps, but 22.7% in full-thickness and 38.7% in split-thickness skin grafts. The aesthetic outcome, evaluated by clinical inspection and a patient satisfaction score, was classified as "unobtrusive" and "good or excellent" for 88.4% of local flaps, 92.6% of sliding flaps, but only for 66.4% of full-thickness and 54% of split-thickness skin grafts.
CONCLUSION: Local flaps and sliding flaps result in better aesthetic and neurological outcomes after reconstruction of facial skin regions. Skin grafts have their indications as an alternative procedure in cases of critical indications for flaps.

Entities:  

Mesh:

Year:  2005        PMID: 15991049     DOI: 10.1007/s10006-005-0626-4

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  25 in total

1.  What causes basal cell carcinoma to be the commonest cancer?

Authors:  J S Gilbody; J Aitken; A Green
Journal:  Aust J Public Health       Date:  1994-06

2.  Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face.

Authors:  J Y Petit; M F Avril; A Margulis; D Chassagne; A Gerbaulet; P Duvillard; A Auperin; M Rietjens
Journal:  Plast Reconstr Surg       Date:  2000-06       Impact factor: 4.730

3.  Recurrent basal cell carcinoma after incomplete resection.

Authors:  J K Robinson; S G Fisher
Journal:  Arch Dermatol       Date:  2000-11

4.  Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck.

Authors:  M R Thissen; F H Nieman; A H Ideler; P J Berretty; H A Neumann
Journal:  Dermatol Surg       Date:  2000-08       Impact factor: 3.398

5.  Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique.

Authors:  Stuart H Bentkover; Donald M Grande; Henry Soto; Beth A Kozlicak; Donna Guillaume; Sheila Girouard
Journal:  Arch Facial Plast Surg       Date:  2002 Apr-Jun

6.  Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules.

Authors:  E Mallon; R Dawber
Journal:  Dermatol Surg       Date:  1996-10       Impact factor: 3.398

7.  Basal cell carcinoma with pulmonary and lymph node metastasis causing death.

Authors:  June K Robinson; Madhu Dahiya
Journal:  Arch Dermatol       Date:  2003-05

8.  Cutaneous micrographic surgery: Mohs procedure.

Authors:  P K Miller; R K Roenigk; D G Brodland; H W Randle
Journal:  Mayo Clin Proc       Date:  1992-10       Impact factor: 7.616

9.  Surgical option for nonmelanoma skin cancer.

Authors:  Patricia Pichardo-Velázquez; Judith Domínguez-Cherit; M a Elisa Vega-Memije; Gabriela Moreno-Coutiño; Héctor Proy
Journal:  Int J Dermatol       Date:  2004-02       Impact factor: 2.736

Review 10.  Interventions for basal cell carcinoma of the skin: systematic review.

Authors:  Fiona Bath-Hextall; Jan Bong; William Perkins; Hywel Williams
Journal:  BMJ       Date:  2004-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.